¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"mixed infection"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • introduced infection
    µµÀÔ°¨¿°
  • inapparent infection
    ¹«Áõ»ó°¨¿°, ºÒÇö¼º°¨¿°
  • indigenous infection
    ÅäÂø°¨¿°
  • indirect infection
    °£Á¢°¨¿°
  • infection
    °¨¿°
  • infection control surveillance
    °¨¿°°ü¸®°¨½Ã
  • infection cycle
    °¨¿°°í¸®, °¨¿°»ç
  • infection focus
    °¨¿°º´ÅÍ
  • infection immunity
    °¨¿°¸é¿ª
  • infection source
    °¨¿°¿ø, Àü¿°¿ø
  • insect-borne infection
    °ïÃæ¸Å°³°¨¿°
  • intercurrent infection
    º´¹ß°¨¿°
  • latent infection
    Àẹ°¨¿°
  • laboratory infection control
    °Ë»ç½Ç°¨¿°°ü¸®
  • local infection
    ±¹¼Ò°¨¿°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • fulminant infection
    Àü°Ý°¨¿°
  • infection focus
    °¨¿°º´ÅÍ
  • generalized infection
    Àü½Å°¨¿°
  • germinal infection
    (¢¡heredoinfection) À¯Àü°¨¿°
  • hematogenous infection
    Ç÷Çà°¨¿°
  • herd infection
    Áý´Ü°¨¿°
  • herpes simplex infection
    ´Ü¼øÇ츣Æä½º°¨¿°
  • hospital acquired infection
    ¿ø³»°¨¿°, º´¿ø°¨¿°
  • household infection
    Áý¾È°¨¿°
  • infection
    °¨¿°
  • inapparant infection
    ¹«Áõ»ó°¨¿°, ºÒÇö¼º°¨¿°
  • indigenous infection
    ÅäÂø°¨¿°
  • indirect infection
    °£Á¢°¨¿°
  • infection immunity
    °¨¿°¸é¿ª
  • infection route
    °¨¿°°æ·Î
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • hospital infection =nosocomial i.
    ¿ø³»°¨¿°(¡­°¨¿°), º´¿ø°¨¿°.
  • hospital infection control
    ¿ø³»<º´¿ø>°¨¿°°ü¸®
  • huma immunodeficiency virus,follicular dendritic cell infection by
    ¿©Æ÷»ó¼öÁö¼¼Æ÷°¨¿°
  • inapparant infection
    ºÒÇö°¨¿°
  • inapparent infection
    ºÒÇö¼º °¨¿°.
  • indirect contact infection
    °£Á¢Á¢Ã˰¨¿° <Àü¿°>.
  • indirect infection
    °£Á¢°¨¿°.
  • infection
    °¨¿°(Êïæø), Àü¿°(îîæø).
  • infection
    °¨¿°
  • infection allergy
    °¨¿°(Êïæø)¾Ë·¹¸£±â.
  • infection by dirt
    ¿À¹°°¨¿°(çýÚªÊïæø).
  • infection control study
    °¨¿°°ü¸®¿¬±¸
  • infection control surveillance
    °¨¿°°ü¸®°¨½Ã
  • infection cycle
    °¨¿°»ç, °¨¿°È¯
  • infection focus
    °¨¿°¼Ò(Êïæøáµ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • mixed germ cell tumors
    È¥ÇÕ ¹è¾Æ¼¼Æ÷ Á¾¾ç
  • mixed gland
    º¹ÇÕ»ù, È¥ÇÕ¼±(ûèùêàÍ).
  • mixed gonadal dysgenesis
    È¥ÇÕÇü¼º¼±ÀÌ»ý¼ºÁõ.
  • mixed gonadal dysgenesis
    È¥ÇÕÇü ¼º¼±ÀÌ»ó¹ß»ýÁõ.
  • mixed hearing loss
    È¥ÇÕ¼º ³­Ã»(ÊÙËÛ˻̧).
  • mixed hearing loss
    È¥ÇÕ(¼º) ³­Ã»
  • mixed indicator
    È¥ÇÕÁö½Ã¾à(¡­ò¦ãÆå·).
  • mixed joint
    È¥ÇÕ °üÀý(¡­Î¼ï½).
  • mixed ketone
    È¥ÇÕÄÉÅæ.
  • mixed leukemia
    È¥ÇÕ¼º ¹éÇ÷º´(¡­ÛÜúìÜ»).
  • mixed leukemia
    È¥ÇÕ¼º ¹éÇ÷º´(?ËÑÌ´ËÓ).
  • mixed liquor
    È¥ÇÕ¾×(ûèùêäû).
  • mixed lymphocytc culture
    È¥ÇÕ¸²ÇÁ±¸¹è¾ç
  • mixed lymphocyte culture
    È¥ÇÕ¸²ÇÁ±¸¹è¾ç(̴̰?Ë´ËÑËâ).
  • mixed lymphocyte culture
    ¸²ÇÁ±¸È¥ÇÕ¹è¾ç(¡­ûèùêÏ¹ÛÆå×).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
MAVD mixed aortic valve disease
MBT mercaptobenzothiazole; mixed bacterial toxin; myeloblastin
MCAR mixed cell agglutination reaction
MCGN mesangiocapillary glomerulonephritis; minimal change glomerulonephritis; mixed cryoglobulinemia with...
MCL maximum containment laboratory; medial collateral ligament; midclavicular line; midcostal line; mini...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
MLR Mixed lymphocyte response
MLTC Mixed lymphocyte tumor cell cultures
MLTC mixed lymphocyte tumor culture
MMT Mixed mesodermal tumor
MM Mixed micelles
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • infection immunity
    °¨¿° ¸é¿ª
    ÀÌ¹Ì Ç׿øÀÌ °°°Å³ª °ü·ÃµÈ Ç׿øÀ» °¡Áø ¹Ì»ý¹°¿¡ ÀÇÇÑ ÁúȯÀÌ Á¸ÀçÇϱ⠶§¹®¿¡ Àç°¨¿°¿¡ ´ëÇÏ¿© ÀúÇ×·ÂÀÌ ÀÖ´Â »óÅÂ.
  • infection source
    °¨¿°¿ø, Àü¿°¿ø
  • insect-borne infection
    °ïÃæ ¸Å°³ °¨¿°, °ïÃæ ¸Å°³ Àü¿°
  • laboratory infection
    °Ë»ç½Ç °¨¿°
    °Ë»ç½Ç ³»¿¡¼­ÀÇ ¹Ì»ý¹°¿¡ ÀÇÇÑ °¨¿°.
  • legionella infection
    Lagionella °¨¿°
  • leptospira infection
    ·¾Å佺ÇÇ¶ó °¨¿°
  • meningococcal infection
    ¼ö¸· ±¸±Õ °¨¿°, ¼ö¸· ±¸±Õ °¨¿°Áõ
  • mock-infection
    ¸ðÀÇ °¨¿° ½ÇÇè
  • multiple infection
    ´Ù¹ß¼º °¨¿°
  • neonatal infection
    ½Å»ý¾Æ °¨¿°
  • nosocomial infection
    ¿ø³» °¨¿°
    º´¿ø¿¡ °ü°èµÈ ¶Ç´Â º´¿ø¿¡¼­ ±âÀÎµÈ °¨¿°.
  • oral infection
    ±¸°­ °¨¿°, ±¸°­ °¨¿°Áõ
  • orthopoxvirus infection
    ¿À¸£Å䯸½º ¹ÙÀÌ·¯½º °¨¿°
  • parasitic infection
    ±â»ýÃæ °¨¿°
  • polymicrobial infection
    º¹¼ö ±Õ °¨¿°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
close contact infection <epidemiology> An infection which requires close contact, other than sexual contact, between susceptible and infectious individuals, for transmission.
(05 Dec 1998)
whipworm infection <gastroenterology> An infection of the large intestine by Trichuris trichiura.
It may be the most common helminthic infection found in Americans returning from subtropical and tropical areas. Children and the mentally retarded have the highest rate of infection due to a general lack of sanitary habits.
The worms are 30-50 mm in length and attach themselves to the mucosa of the large intestine. Adult worms may live 4-8 years. Treatment is with mebendazole.
(27 Sep 1997)
multi-infection Mixed infection with two or more varieties of microorganisms developing simultaneously.
(05 Mar 2000)
congenital infection: torchs syndrome <radiology> T Toxoplasma, R Rubella, C Cytomegalic inclusion disease (CID, CMV), H Herpes, S Syphilis, transplacentally acquired, congenital infection, celery-stalk metaphyses, especially long bones, intracranial calcification, decreased growth, vascular stenosis (aorta, pulmonary artery)
(12 Dec 1998)
multiple infection <epidemiology> An infection in which an individual is infected by parasites of more than one species.
(05 Dec 1998)
wound infection Invasion of the site of trauma by pathogenic microorganisms.
(12 Dec 1998)
mycobacterium avium-intracellulare infection Nontuberculous infection occurring in humans. This condition is frequently associated with pulmonary disease and recently recognised as an opportunistic infection in aids patients.
(12 Dec 1998)
cross infection <microbiology> Infection transmitted between individuals infected with different pathogenic microorganisms. Any infection which a patient contracts in a health-care institution.
(12 Dec 1998)
cryptogenic infection Bacterial, viral, or other infection, the source of which is unknown.
(05 Mar 2000)
pregnancy danger from urinary tract infection A pregnant woman who develops a uti should be treated promptly to avoid premature delivery of her baby and other risks such as high blood pressure. Some antibiotics are not safe to take during pregnancy. In selecting the best treatment, doctors consider various factors such as the drug's effectiveness, the stage of pregnancy, the mother's health, and potential effects on the foetus.
(12 Dec 1998)
primary HIV infection <infectious disease> The flu-like syndrome that oc immediately after a person contracts HIV. This mini infection precedes seroconversion and is characterised fever, sore throat, headache, skin rash and swollen glands.
(06 Mar 1998)
Salinem infection Infection with Leptospira pyrogenes, reported in Salinem.
Synonym: Salinem infection.
(05 Mar 2000)
scalp infection An infection external to the galea; e.g., folliculitis or cellulitis.
(05 Mar 2000)
screw worm infection Infection with larvae of the blow fly cochliomyia hominivorax (callitroga americanum), a common cause of disease in livestock in the southern and southwestern u.s.a.
(12 Dec 1998)
secondary infection An infection, usually septic, occurring in a person or animal already suffering from an infection of another nature.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á